Related Experiment Video
Updated: Jul 16, 2026

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
Published on: January 30, 2014
Microglial Modulation as a Therapeutic Avenue for Perioperative Neurocognitive Disorders: Unveiling
1Department of Anesthesiology, The Affiliated People's Hospital of Ningbo University, Ningbo, China.
Background:
Perioperative neurocognitive disorders (PND) encompass a spectrum of cognitive impairments that arise from the preoperative phase and can persist for months after surgery, with a prevalence of up to 50% in elderly patients. These disorders, including postoperative delirium and sustained cognitive decline, significantly reduce patient quality of life and impose substantial burdens on healthcare systems. Despite extensive research, the underlying pathophysiological mechanisms remain inadequately understood, limiting the development of effective treatments. Increasing evidence highlights neuroinflammation as a central factor in PND, with microglia-the resident immune cells of the central nervous system-playing a key role in mediating inflammatory responses that lead to cognitive dysfunction.
Methods:
This review comprehensively analyzes the role of microglia in the pathogenesis of PND. It details key perioperative triggers of microglial activation, such as surgical stress, anesthesia, and systemic inflammation. The review further examines preclinical interventions aimed at modulating microglial function, including depletion strategies, polarization toward anti-inflammatory phenotypes, and inhibition of inflammatory pathways like NF-κB and NLRP3.
Results:
Preclinical studies demonstrate that dysregulated microglial activation results in excessive production of pro-inflammatory cytokines, oxidative stress, and synaptic disruptions, which collectively contribute to neuronal injury and cognitive impairment. Interventions targeting microglial activation have shown efficacy in reducing neuroinflammation and preserving cognitive function in animal models.
Conclusions:
Targeting microglial activation represents a promising strategy for alleviating PND. However, challenges remain in clinical translation, necessitating advanced drug delivery platforms, personalized therapeutic approaches, and rigorous clinical validation. Advances in microglial modulation hold potential for improving postoperative cognitive outcomes and enhancing patient recovery.
More Related Videos
12:48In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma
Published on: May 11, 2015
10:21Characterization and Isolation of Mouse Primary Microglia by Density Gradient Centrifugation
Published on: February 16, 2018
Related Concept Videos
Ligand-gated Ion Channels
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment